Mass spectrometry based metabolomic approaches in urinary biomarker study of women's cancers. - Wikidata - wikimedia - TriplyDB

Mass spectrometry based metabolomic approaches in urinary biomarker study of women's cancers.

Mass spectrometry based metabolomic approaches in urinary biomarker study of women's cancers.

http://www.wikidata.org/entity/Q46245921

about

Review: toxicometabolomics Identification of metabolites in the normal ovary and their transformation in primary and metastatic ovarian cancer Application of Holistic Liquid Chromatography-High Resolution Mass Spectrometry Based Urinary Metabolomics for Prostate Cancer Detection and Biomarker Discovery Capillary electrophoresis mass spectrometry-based saliva metabolomics identified oral, breast and pancreatic cancer-specific profiles Determination of Water-Soluble Components of Abdominal Secretion of Grasshopper (Chorthippus spp.) by GC/MS/MS in Search for Potential Wound Healing Agents Conformational change in transfer RNA is an early indicator of acute cellular damage Urinary nucleosides as biomarkers of breast, colon, lung, and gastric cancer in Taiwanese.Serum and urine metabolite profiling reveals potential biomarkers of human hepatocellular carcinoma.Identification of serum biomarkers of hepatocarcinoma through liquid chromatography/mass spectrometry-based metabonomic method.Mass spectrometry-based metabolomics: applications to biomarker and metabolic pathway research.Metabolomics for Biomarker Discovery: Moving to the Clinic Systemic Metabolomic Changes in Blood Samples of Lung Cancer Patients Identified by Gas Chromatography Time-of-Flight Mass Spectrometry Utilization of metabolomics to identify serum biomarkers for hepatocellular carcinoma in patients with liver cirrhosis Metabonomic signature analysis of cervical carcinoma and precancerous lesions in women by (1)H NMR spectroscopy.Metabolomics of human breast cancer: new approaches for tumor typing and biomarker discovery.Advances in gas chromatographic methods for the identification of biomarkers in cancer.Metabolomic analysis with GC-MS to reveal potential metabolites and biological pathways involved in Pb &Cd stress response of radish roots.Correlation analysis of urine metabolites and clinical staging in patients with ovarian cancer.Use of Plasma Metabolomics to Identify Diagnostic Biomarkers for Early Stage Epithelial Ovarian Cancer.Serum metabolome profiles characterized by patients with hepatocellular carcinoma associated with hepatitis B and C.Detection of inflammatory biomarkers in saliva and urine: Potential in diagnosis, prevention, and treatment for chronic diseases Global metabolomics reveals urinary biomarkers of breast cancer in a mcf-7 xenograft mouse model.A review of applications of metabolomics in cancer.Review of mass spectrometry-based metabolomics in cancer research.Triple-negative breast cancer: present challenges and new perspectives.The role of metabolites and metabolomics in clinically applicable biomarkers of disease.The state-of-the-art determination of urinary nucleosides using chromatographic techniques "hyphenated" with advanced bioinformatic methods.Metabolomics and surgical oncology: Potential role for small molecule biomarkers.Recent advances in metabolomics in oncology.Nuclear magnetic resonance-based analysis of urine for the rapid etiological diagnosis of pneumonia.Metabolomics for tumor marker discovery and identification based on chromatography-mass spectrometry.Mass spectrometric based approaches in urine metabolomics and biomarker discovery.Toxicometabolomics of urinary biomarkers for human gastric cancer in a mouse model.Metabolomics of biomarker discovery in ovarian cancer: a systematic review of the current literature.Effects of antibiotic antitumor drugs on nucleotide levels in cultured tumor cells: an exploratory method to distinguish the mechanisms of antitumor drug action based on targeted metabolomics Analysis of Raw Biofluids by Mass Spectrometry Using Microfluidic Diffusion-Based Separation.Urinary hydrophilic and hydrophobic metabolic profiling based on liquid chromatography-mass spectrometry methods: Differential metabolite discovery specific to ovarian cancer.Higher detectability method for the analysis of nucleosides, putative tumor biomarkers, in blood serum samples by CE-UV with reversed EOF.Saturated fatty acids as possible important metabolites for epithelial ovarian cancer based on the free and esterified fatty acid profiles determined by GC-MS analysis.Towards automatic metabolomic profiling of high-resolution one-dimensional proton NMR spectra.

P2860

Q27001191-072A7118-5E85-4FBA-97B9-F6DE79E2AE59 Q28478197-F6210226-6B41-4D46-98C4-C608A23C73BA Q28534070-98C19986-3C5B-403D-9313-97A026E7C227 Q33639706-FCE3DE47-771E-4F24-AF24-E0813D7F95E5 Q33953629-13D92DE6-59AF-4AE9-8359-6AD9E9854E12 Q34260059-41A89259-D8AC-420F-B0A2-902D838AEB9C Q35075221-679A51F8-BA62-4008-BD93-A904DC2C679C Q35098539-E05BDB7E-83CC-4CAF-A586-B95B2C11018F Q35211302-3A32533B-477B-4F2A-9DF8-2E4217E770B9 Q35571752-0DE093FC-F7AA-4D8A-BC44-2FAFBD56117D Q35674401-EFEAEE87-A0E8-49DC-B16A-44D63D8D4EEA Q35829888-92BB8376-585B-4DF5-B327-EBD1C6DA71E0 Q36165635-2B67A4D0-3568-46C8-8FE6-383402B4D3BB Q36224709-DFCD57CC-5EE4-4DED-B3E9-F5FBD65917E5 Q36245156-B29A07AD-A9F6-48CE-A2FD-D38B16F2E818 Q36316592-B73A9278-2C94-4BD9-8864-9DF839EB831C Q36379516-E0163D2C-235D-4205-9C36-7D4E4A1F393C Q36411755-D2CC4821-DFA8-44DE-B20B-8BFD14D33819 Q37068001-46ECCD1A-1805-4B92-8168-117C828CFC00 Q37096702-11C8EA7C-2710-4AF6-8B16-A30EF7276642 Q37107248-880922B6-7436-403C-9C5C-6A5C52F05BEB Q37512809-6791E434-6D6F-4893-8512-876873B7B068 Q37512830-8FA2AAF1-3FD1-455A-8564-45E357E6F691 Q37550758-E0A532CC-5463-4F50-91D9-26EFE52B824C Q37764168-17D0268E-097D-49D2-8C50-499BE59CDF23 Q37800811-D35736B8-E065-41C7-8787-089A3A42CE6A Q37848165-06ECEEE4-15EB-4515-825E-65510A068F40 Q37852648-DE2088CD-BF76-49EC-8A5E-81280D2FC6DA Q37990967-1CB9D31E-1059-4F31-BFFE-B241041F14E6 Q38088723-120A53D9-0F1C-43D1-9757-D0B97A8D8B97 Q38103592-280C7F6F-67C0-4C2E-B8D8-EB7A898F2B7F Q38424072-AD18F71D-38D3-4B41-A951-FDF575B16E34 Q39643027-01960B20-4C80-4C09-830F-CF4ED8DE1F46 Q41403906-61F7BC99-0AC1-479D-A68C-4CA0AC536954 Q42005150-8AF21AFF-F281-4F58-AA54-E8AD543549CC Q47917964-F5905748-0F82-47BF-82F4-7126CFB23A16 Q49057114-88912120-34E0-4DAA-B682-943012C501F5 Q50948368-D0F730E6-9C9F-4116-A51B-B545907A9EAF Q51113701-3A5C125C-0E78-4F55-97E4-FFE203C2CB36 Q51598103-0FA0021B-F94A-4A4A-832E-11173839D113

P2860

Mass spectrometry based metabolomic approaches in urinary biomarker study of women's cancers.

http://www.wikidata.org/entity/Q46245921

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年学术文章

@wuu

2008年学术文章

@zh-cn

2008年学术文章

@zh-hans

2008年学术文章

@zh-my

2008年学术文章

@zh-sg

2008年學術文章

@yue

2008年學術文章

@zh

2008年學術文章

@zh-hant

name

Mass spectrometry based metabo ...... rker study of women's cancers.

@en

Mass spectrometry based metabo ...... rker study of women's cancers.

@nl

type

label

Mass spectrometry based metabo ...... rker study of women's cancers.

@en

Mass spectrometry based metabo ...... rker study of women's cancers.

@nl

prefLabel

Mass spectrometry based metabo ...... rker study of women's cancers.

@en

Mass spectrometry based metabo ...... rker study of women's cancers.

@nl

P1433

Q46245921-33AF5374-B537-4131-9CDF-0201CBDC3EAB

P1476

Q46245921-C4080A0D-6EB6-4E63-B767-FD47B408721B

P2093

Q46245921-14C96780-519C-4CB4-9AB2-7EC46311D3F7

Q46245921-23405199-0E2B-4C41-85A5-C8A5533F6398

Q46245921-2B76351B-65A3-4BC7-89E1-FAE7DCC17B54

Q46245921-2EA3BEB9-8E79-4D8B-A106-4A5E033A9047

Q46245921-A46A8AC3-7B2E-4E2C-9EDE-B3E05AE1C8BC

Q46245921-AD0D5069-1310-41D0-8783-745E34690365

Q46245921-D18D6E3D-2E11-4FDE-91A6-3D87E3A164C7

P304

Q46245921-80381B3A-A823-4D7A-8047-89EABF6B0103

P31

Q46245921-DF82F787-54F6-43E1-9210-6212CA0791C4

P356

Q46245921-D694B94E-4C8F-483D-99BD-F7E4D6BC0DE3

P433

Q46245921-FB4297AC-4229-4740-8724-FEE087F5B95C

P478

Q46245921-B8881C2A-F573-4076-A1F5-46888B33B546

P50

Q46245921-39E43790-9DA4-4038-99FD-9ADBCD4C3007

Q46245921-4D971CA2-EE07-423B-8F7C-1DC2F525FA22

Q46245921-51AC692A-BB77-44D0-AAD1-85B182C0137A

P577

Q46245921-326CE087-6465-4E6B-BDB9-5ACC64FB4044

P698

Q46245921-68523C65-62D6-44BD-9D1F-8BE49A989604

P921

Q46245921-CE291E62-006B-431A-A74E-BABC390F4972

P356

J.CCA.2008.10.014

P1433

Clinica Chimica Acta

P1476

Mass spectrometry based metabo ...... arker study of women's cancers

@en

P2093

Byung Hwa Jung

http://www.w3.org/2001/XMLSchema#string

Gu Kong

http://www.w3.org/2001/XMLSchema#string

Jeongae Lee

http://www.w3.org/2001/XMLSchema#string

Kyung Mi Kim

http://www.w3.org/2001/XMLSchema#string

Man Ho Choi

http://www.w3.org/2001/XMLSchema#string

Seok Jin Nam

http://www.w3.org/2001/XMLSchema#string

Sunghoon Kim

http://www.w3.org/2001/XMLSchema#string

P304

63-69

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.CCA.2008.10.014

http://www.w3.org/2001/XMLSchema#string

P433

1-2

http://www.w3.org/2001/XMLSchema#string

P478

400

http://www.w3.org/2001/XMLSchema#string

P50

Bong Chul Chung

P577

2008-10-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19010317

http://www.w3.org/2001/XMLSchema#string

P921